Posts

Smart Cancer Resources & Research Guide 2026: A Patient-First Map of Diagnosis, Biomarkers, Treatment, Immunotherapy, Resistance & Integrative Oncology

Image
OneDayMD Cancer Resource Library · Network Index · Published September 17, 2026 · Last reviewed and updated October 2026 (v2.1) Cancer information is no longer confined to a single textbook, treatment guideline, or hospital website — and cancer guides should not be limited to oncologists. Modern oncology now spans pathology, staging, molecular biomarkers, precision medicine, prevention, surgery, radiation, chemotherapy, targeted therapy, immunotherapy, cellular therapy, cancer metabolism, treatment resistance, supportive care, and clinical research. This OneDayMD guide brings those subjects together in one navigable resource. Rather than hundreds of disconnected articles, it offers a pathway through the evidence and links directly to deeper OneDayMD, SmartCancer, and Cancer Advisor resources. Quick Answer This page is a map, not a single treatment guide — it connects the OneDayMD network's cancer content by the question you're actually asking. Newly diagnosed and w...
Post a Comment
Read more

Top 17 Cancer Fighting Supplements: Evidence Based Literature Review (2026 Update)

Image
Medically reviewed by Dr. Frank Yap, MD  |  Written by OneDayMD Editorial Team  |  Last updated October 2026 Quick Answer No single dietary supplement is established as a universal cancer treatment. Of the 17 supplements reviewed here, the deepest human evidence supports vitamin D3 (with K2 and magnesium) , polysaccharide-K (PSK) from turkey tail as an add-on to chemotherapy in Japanese trials, berberine for preventing colorectal adenoma recurrence, omega-3 fatty acids , curcumin and green tea EGCG . Even these show mixed rather than uniformly positive results. Melatonin looked promising in small trials, but the largest randomized trial found no benefit in early-stage lung cancer. A few supplements, namely high-dose beta-carotene, vitamin E and long-term high-dose B6/B12 , have been linked to higher cancer risk in specific groups. No supplement replaces conventional cancer treatment, and antioxidant pills are generally discouraged during chemo...
Post a Comment
Read more

Exploring Ivermectin, Mebendazole and Fenbendazole as Aggressive Cancer Treatments: Research, Protocols, and Controversies (2026)

Image
Medically Reviewed by: OneDayMD Editorial Team | Evidence Synthesis & Safety Review | Last Updated: October 2026 Quick Answer Ivermectin, fenbendazole, and mebendazole are antiparasitic drugs with laboratory evidence of anticancer activity.  Together, ivermectin and mebendazole exhibit 37 distinct anticancer mechanism classes across 25 human malignancies, highlighting their exceptionally broad potential for therapeutic repurposing in oncology. Both are oral, widely available generic drugs that are well-tolerated alongside chemotherapy. Large, prospective, double-blind, parallel-group, randomized trials of combination ivermectin-mebendazole are urgently needed across a broad array of human malignancies. Patients should discuss any interest in these agents openly with their oncology team rather than self-administering veterinary or compounded formulations.  This article separates the genuine research question from the unverified claims, and outlines what to discus...
Post a Comment
Read more

Archive

Show more